These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
787 related articles for article (PubMed ID: 27438990)
1. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas. Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990 [TBL] [Abstract][Full Text] [Related]
2. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Kim JH; Bae JM; Cho NY; Kang GH Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis. Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157 [TBL] [Abstract][Full Text] [Related]
4. Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions. Cocco E; Benhamida J; Middha S; Zehir A; Mullaney K; Shia J; Yaeger R; Zhang L; Wong D; Villafania L; Nafa K; Scaltriti M; Drilon A; Saltz L; Schram AM; Stadler ZK; Hyman DM; Benayed R; Ladanyi M; Hechtman JF Cancer Res; 2019 Mar; 79(6):1047-1053. PubMed ID: 30643016 [TBL] [Abstract][Full Text] [Related]
5. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF Fennell LJ; Jamieson S; McKeone D; Corish T; Rohdmann M; Furner T; Bettington M; Liu C; Kawamata F; Bond C; Van De Pols J; Leggett B; Whitehall V BMC Cancer; 2018 Jan; 18(1):35. PubMed ID: 29304767 [TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of recurrent oncogenic fusion in mismatch repair-deficient colorectal carcinoma with hypermethylated MLH1 and wild-type BRAF and KRAS. Wang J; Yi Y; Xiao Y; Dong L; Liang L; Teng L; Ying JM; Lu T; Liu Y; Guan Y; Pang J; Zhou L; Lu J; Zhang Z; Liu X; Liang X; Zeng X; Yi X; Zhou W; Xia X; Yang L; Zhang J; Kopetz S; Futreal PA; Wu H; Liang Z Mod Pathol; 2019 Jul; 32(7):1053-1064. PubMed ID: 30723297 [TBL] [Abstract][Full Text] [Related]
8. Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas. García-Solano J; Conesa-Zamora P; Carbonell P; Trujillo-Santos J; Torres-Moreno D D; Pagán-Gómez I; Rodríguez-Braun E; Pérez-Guillermo M Int J Cancer; 2012 Oct; 131(8):1790-9. PubMed ID: 22287190 [TBL] [Abstract][Full Text] [Related]
9. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival. Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419 [TBL] [Abstract][Full Text] [Related]
10. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504 [TBL] [Abstract][Full Text] [Related]
11. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions. Naito T; Nosho K; Ito M; Igarashi H; Mitsuhashi K; Yoshii S; Aoki H; Nomura M; Sukawa Y; Yamamoto E; Adachi Y; Takahashi H; Hosokawa M; Fujita M; Takenouchi T; Maruyama R; Suzuki H; Baba Y; Imai K; Yamamoto H; Ogino S; Shinomura Y World J Gastroenterol; 2014 Aug; 20(29):10050-61. PubMed ID: 25110432 [TBL] [Abstract][Full Text] [Related]
12. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea. Kim KM; Lee EJ; Ha S; Kang SY; Jang KT; Park CK; Kim JY; Kim YH; Chang DK; Odze RD Am J Surg Pathol; 2011 Sep; 35(9):1274-86. PubMed ID: 21836485 [TBL] [Abstract][Full Text] [Related]
13. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes. Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506 [TBL] [Abstract][Full Text] [Related]
14. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients. Ye JX; Liu Y; Qin Y; Zhong HH; Yi WN; Shi XY World J Gastroenterol; 2015 Feb; 21(5):1595-605. PubMed ID: 25663779 [TBL] [Abstract][Full Text] [Related]
15. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation. Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244 [TBL] [Abstract][Full Text] [Related]
17. Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E. Mesteri I; Bayer G; Meyer J; Capper D; Schoppmann SF; von Deimling A; Birner P Mod Pathol; 2014 Jan; 27(1):135-44. PubMed ID: 23887306 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. Bettington M; Walker N; Rosty C; Brown I; Clouston A; McKeone D; Pearson SA; Leggett B; Whitehall V Gut; 2017 Jan; 66(1):97-106. PubMed ID: 26475632 [TBL] [Abstract][Full Text] [Related]
19. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability. Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry for annexin A10 can distinguish sporadic from Lynch syndrome-associated microsatellite-unstable colorectal carcinoma. Pai RK; Shadrach BL; Carver P; Heald B; Moline J; Church J; Kalady MF; Burke CA; Plesec TP; Lai KK; Gonzalo DH; Pai RK Am J Surg Pathol; 2014 Apr; 38(4):518-25. PubMed ID: 24625416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]